JPS62259597A - Enzymic synthesis of n-protected peptide - Google Patents

Enzymic synthesis of n-protected peptide

Info

Publication number
JPS62259597A
JPS62259597A JP10431986A JP10431986A JPS62259597A JP S62259597 A JPS62259597 A JP S62259597A JP 10431986 A JP10431986 A JP 10431986A JP 10431986 A JP10431986 A JP 10431986A JP S62259597 A JPS62259597 A JP S62259597A
Authority
JP
Japan
Prior art keywords
water
layer
solution
amino acid
mmot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10431986A
Other languages
Japanese (ja)
Other versions
JPH0634745B2 (en
Inventor
Yutaka Honda
裕 本多
Toyohito Tsuchiya
豊人 土屋
Tadashi Takemoto
正 竹本
Toshihide Yugawa
湯川 利秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP10431986A priority Critical patent/JPH0634745B2/en
Publication of JPS62259597A publication Critical patent/JPS62259597A/en
Publication of JPH0634745B2 publication Critical patent/JPH0634745B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To efficiently obtain the titled compound, by reacting an N-protected amino acid with an amino acid in an aqueous layer in a two-phase system reaction medium of an organic solvent containing a quaternary ammonium salt, etc., and water using a proteolytic enzyme and migrating the resultant product to an organic solvent phase. CONSTITUTION:An N-protected amino acid, e.g. N-acetyl-L-aspartic acid, etc., or a derivative thereof is reacted with an amino acid, e.g., L-phenylalanine, etc., or a derivative thereof in an aqueous layer in a two-phase system reaction medium of a water-immiscible organic solvent containing a dissolved quaternary ammonium salt, e.g. trioctylmethylammonium chloride, etc., or quaternary phosphonium salt and water using a proteolytic enzyme to form an N-protected peptide containing one or more carboxyl groups. The resultant N-protected peptide is then converted into a lipophilic quaternary ammonium salt or phosphonium salt and migrated to the organic solvent phase to afford the aimed compound.

Description

【発明の詳細な説明】 本発明は、N−保護ペプチドの酵素的合成法に関し、更
に詳しくは少なくとも1つのカルボキシル基をもつN−
保護ペプチドの酵素的合成法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for the enzymatic synthesis of N-protected peptides, and more particularly to a method for the enzymatic synthesis of N-protected peptides having at least one carboxyl group.
This invention relates to a method for enzymatically synthesizing protected peptides.

近年、ペプチド合成において、酵素を用いる方法がセラ
ミ化を起とさ々いという理由から注目を集め、種々のペ
プチド合成への利用が試みられている。ところで、この
方法では酵素として蛋白分解酵素を用いる為、通例、一
旦生成した一?ノチドの加水分解反応を伴う。因みに、
この蛋白分解酵素を用いる反応は、周知の如く、平衡反
応である。
In recent years, methods using enzymes in peptide synthesis have attracted attention because they frequently cause ceramization, and attempts have been made to utilize them in various peptide syntheses. By the way, since this method uses proteolytic enzymes as enzymes, it is common to use proteolytic enzymes once they have been generated. Accompanied by hydrolysis reaction of notide. By the way,
As is well known, this reaction using a protease is an equilibrium reaction.

従って、ペプチド結合生成反応を効率よく進める為には
加水分解反応を抑制するのが重要なポイントであシ、現
状では、生成物を沈殿させて反応系外に除き加水分解反
応を妨げる方法や、水と混和しない有機溶媒を水に添加
した2相系反応媒体中で反応を行ない、生成物を有機溶
媒層側に抽出して反応系外に除く方法が主として用いら
れている。しかし、これらの方法では、生成物にカルボ
キシル基を持つものなどでは、通常の酵素反応の条件の
下では水に対する溶解度が高い為、沈殿もせず、有機溶
媒層にも抽出されず、反応は効率よく進行しない。特に
、基質のアミノ基の保護基として親水性の高いホルミル
基(以下、Forと略記する。)やアセチル基(以下A
eと略記する。)を用いた場合は特に顕著である。とこ
ろで蛋白分解酵素にはエンド型とエキソ型があるが、エ
キソ型の酵素であるカルがキシペゾチダーゼを用いた場
合には、アミノ基側の基質としてアミノ酸を使用スルの
で、生成物のペプチドのカルd?キシル末端は遊離のカ
ルボキシル基となり、正に上記の例【あてはまる。
Therefore, in order to efficiently proceed with the peptide bond formation reaction, it is important to suppress the hydrolysis reaction.Currently, there are methods to prevent the hydrolysis reaction by precipitating the product and removing it from the reaction system, Mainly used is a method in which the reaction is carried out in a two-phase reaction medium in which an organic solvent that is immiscible with water is added to water, and the product is extracted into the organic solvent layer and removed from the reaction system. However, in these methods, products with carboxyl groups have high solubility in water under normal enzyme reaction conditions, so they do not precipitate or are extracted into the organic solvent layer, and the reaction is not efficient. It doesn't progress well. In particular, highly hydrophilic formyl group (hereinafter abbreviated as For) and acetyl group (hereinafter A
It is abbreviated as e. ) is particularly noticeable. By the way, there are two types of proteolytic enzymes: endo-type and exo-type. When Cal, an exo-type enzyme, uses xipezotidase, an amino acid is used as the substrate on the amino group side, so the Cal-d of the product peptide is ? The xyl terminal becomes a free carboxyl group, and the above example applies exactly.

そこで本発明者らは、N−保護したアミノ酸あるいはそ
の誘導体とアミノ酸あるいはその誘導体を蛋白分解酵素
を用いて反応させ、少なくとも1つのカルボキシル基を
有するN−保護ペプチドを効率よく合成する方法につき
鋭意検討した結果、驚くべきことに、本酵素反応を有機
溶媒と水との2相系反応媒体中で4級アンモニウム塩あ
るいは4級ホスホニウム塩の存在下に行なうことにょシ
、本来有機溶媒層には移行しない生成物を親油性の4級
アンモニウム塩あるいは4級ホスホニウム塩として、有
機溶媒層に移行させ、ペプチド生成反応を効率よく進行
させ得る事を見出し、本発明を完成させるに至った。
Therefore, the present inventors have conducted intensive studies on a method for efficiently synthesizing an N-protected peptide having at least one carboxyl group by reacting an N-protected amino acid or its derivative with an amino acid or its derivative using a protease. As a result, surprisingly, when this enzyme reaction is carried out in the presence of a quaternary ammonium salt or quaternary phosphonium salt in a two-phase reaction medium of organic solvent and water, no migration occurs in the organic solvent layer. The present inventors have discovered that the peptide production reaction can be efficiently progressed by transferring the product that does not react as a lipophilic quaternary ammonium salt or quaternary phosphonium salt to an organic solvent layer, and have completed the present invention.

本発明方法は、近年、優れた甘味剤として注目すしてい
るアスパルテーム(α−L−アスパルチルーL−フェニ
ルアラニンメチルエステル)の重要な製造中間体である
N−保護−α−L−アスパルチルーL−フェニルアラニ
ン(以下、N−保護−α−APと略記する。)の合成に
適用すれば特に効力を発揮する。即ち、N−保護−α−
APは容易にアスパルテームに変換される(特公昭60
−50.200)、が、N−保護−α−APの製法とし
ては唯一、N−保護−L−アスノ母うギン酸無水物とL
−フェニルアラニンを酢酸中で反応させる方法がしられ
ている(特公昭55−26,133 )が、この方法で
HN−保時−β−L−アスパルチルーL−フェニルアラ
ニンが副生ずることや、腐食性の高い酢酸を使用するこ
となど、優れた方法とは言いがたい。本発明方法を適用
すれば、上記欠点を克服し、N−保護−α−APのみを
効率よく合成することができる。
The method of the present invention utilizes N-protected-α-L-aspartyl-L-phenylalanine (α-L-aspartyl-L-phenylalanine methyl ester), which is an important intermediate in the production of aspartame (α-L-aspartyl-L-phenylalanine methyl ester), which has recently attracted attention as an excellent sweetener. It is particularly effective when applied to the synthesis of N-protected-α-AP (hereinafter abbreviated as N-protected-α-AP). That is, N-protected-α-
AP is easily converted to aspartame (Special Publications Act 1986)
-50.200), is the only method for producing N-protected-α-AP that uses N-protected-L-asnocarboxylic anhydride and L-protected α-AP.
- A method of reacting phenylalanine in acetic acid is known (Japanese Patent Publication No. 55-26, 133), but this method produces by-products of HN-holding-β-L-aspartyl-L-phenylalanine and is corrosive. It is hard to say that it is a good method, such as using high-quality acetic acid. By applying the method of the present invention, the above drawbacks can be overcome and only N-protected-α-AP can be efficiently synthesized.

実施例に示すように、本発明方法を用いると、水中にお
ける酵素反応に比し、生成するN−保護ペプチドの収率
が大幅に向上する。例えば、保護基がアセチル基の場合
、水溶液中の反応では、N−アセチルーα−L−アスノ
母ルチルーL−フェニルアラニン(以下、Ac−α−A
Pと略記する。)の収率は5.2 % (比較例2)で
あるが、本発明方法をもちいるとAe−α−APの収率
は20%(実施例7)に向上する。又、保護基がベンジ
ルオキシカルがニル基の場合も、水溶液中の反応ではN
−ベンジルオキシカルがニルーα−L−アスパルチルー
L−フェニルアラニンの収率は2.4 係(比較例6)
であるが、本発明方法を用いると8チ(実施例15)に
向上した。
As shown in the Examples, when the method of the present invention is used, the yield of the N-protected peptide produced is significantly improved compared to an enzymatic reaction in water. For example, when the protecting group is an acetyl group, in the reaction in an aqueous solution, N-acetyl-α-L-asno-rutile-L-phenylalanine (hereinafter referred to as Ac-α-A
It is abbreviated as P. ) is 5.2% (Comparative Example 2), but when the method of the present invention is used, the yield of Ae-α-AP is improved to 20% (Example 7). Also, when the benzyloxycar protecting group is a nyl group, in the reaction in an aqueous solution, N
- The yield of α-L-aspartyl-L-phenylalanine is 2.4% (Comparative Example 6)
However, when the method of the present invention was used, it improved to 8 inches (Example 15).

本発明方法だよると、第1に2相系反応媒体を用いてN
−保護ペプチド生成反応を行ない、生成LAN−保護−
(′ゾチドを親油性の4級アンモニウム塩あるいは4級
ホスホニウム塩として有機溶媒層に移行させることによ
りペプチド生成反応を効率よく進行させ得るが、また、
第2にN−保護アミノ酸あるいはその誘導体とアミノ酸
あるいはその誘導体とを水中で蛋白分解酵素を用いて反
応させた後、有機溶媒と4級アンモニウム塩あるいは4
級ホスホニウム塩を添加し、生成したN−保護ペプチド
と原料のN−保護アミノ酸あるいはその誘導体とアミノ
酸あるいはその誘導体の有機溶媒/水の分配係数の差を
利用して生成したN−保護ペプチドを有機溶媒層に抽出
することも出来る。
According to the method of the present invention, firstly, a two-phase reaction medium is used to
-Perform the protected peptide production reaction and generate LAN-protection-
(The peptide production reaction can proceed efficiently by transferring 'zotide as a lipophilic quaternary ammonium salt or quaternary phosphonium salt to the organic solvent layer, but
Second, after reacting the N-protected amino acid or its derivative with the amino acid or its derivative in water using a protease, an organic solvent and a quaternary ammonium salt or
Using the difference in organic solvent/water partition coefficient between the N-protected peptide, the raw material N-protected amino acid or its derivative, and the amino acid or its derivative, the N-protected peptide is converted into an organic It is also possible to extract into a solvent layer.

:有機溶媒層と水層とを分離した後、第1の方法により
、水層に再度、4級アンモニウム塩あるいは4級ホスホ
ニウム塩を含む有機溶媒を加えて2層系反応媒体中でペ
プチド生成反応を行ない、これを繰返して行なえば、ペ
プチド生成反応を効率よく進行させることが出来るのは
いうまでもない。
: After separating the organic solvent layer and the aqueous layer, by the first method, an organic solvent containing a quaternary ammonium salt or a quaternary phosphonium salt is added to the aqueous layer again to perform a peptide production reaction in a two-layer reaction medium. It goes without saying that if this is carried out repeatedly, the peptide production reaction can proceed efficiently.

もちろん、第2の方法によってペプチド生成反応を繰返
し行なってもよい。
Of course, the peptide production reaction may be repeated by the second method.

本発明方法において用いられるN−保護アミノ酸および
その誘導体のN−保護基としては、通常のペプチド合成
において使用される保護基、例えば、ホルミル基、アセ
チル基、ベンジルオキシカルがニル基、t−プチルオキ
シ力ルデニル基、フェノキシアセチル基、l−メチル−
2−アセチルビニル基及びアセトアセチル基が用いられ
る他、アミノ酸残基も用いられるが、中でもホルミル基
、アセチル基、ペンノルオキシカルがニル基が好適にも
ちいられる。アミノ酸残基がN−保護基となっているN
−保護アミノ酸としては、例えば、N−ホルミルーL−
アラニル−L−アスパラギン酸がある。また、N−保護
アミノ酸誘導体としては、例えば、N−ホルミル−L−
アスパラギン酸−α−メチルエステルがある。
The N-protecting groups of the N-protected amino acids and their derivatives used in the method of the present invention include protecting groups used in ordinary peptide synthesis, such as formyl group, acetyl group, benzyloxycarboxyl group, t-butyloxycarboxyl group, and -rudenyl group, phenoxyacetyl group, l-methyl-
In addition to 2-acetylvinyl group and acetoacetyl group, amino acid residues are also used, and among them, formyl group, acetyl group, pennoloxycar, and nyl group are preferably used. N where the amino acid residue is an N-protecting group
-Protected amino acids include, for example, N-formyl-L-
Alanyl-L-aspartic acid. Further, as the N-protected amino acid derivative, for example, N-formyl-L-
Aspartic acid-α-methyl ester.

N−保護アミノ酸またはその誘導体と反応させるアミノ
酸またはその誘導体のうち、最後者のアミノ酸誘導体と
しては、例えば、L−フェニルアラニンメチルエステル
がある。
Among the amino acids or derivatives thereof to be reacted with the N-protected amino acid or derivative thereof, the last amino acid derivative is, for example, L-phenylalanine methyl ester.

なお、N−保護アミノ酸またはその誘導体とそれに反応
させるアミノ酸またはその誘導体との組合せは、生成す
るN−保護−e7″チドまたはその誘導体が少くとも1
つの遊離のカルボキシル基をもつものでなければならな
い。これは、前述のように、生成し九N−保瞳ベプチド
またはその誘導体を有機溶媒に溶解している4級アンモ
ニウム塩または4級ホスホニウム塩のカチオン部分と結
合させて新たにN−保護ペプチドまたはその誘導体の親
油性の4級アンモニウム塩または4級ホスホニウム塩と
するためである。
In addition, the combination of the N-protected amino acid or its derivative and the amino acid or its derivative to be reacted with it is such that the resulting N-protected-e7''tide or its derivative is at least 1
It must have one free carboxyl group. As mentioned above, the generated 9N-homitomi peptide or its derivatives are combined with the cation moiety of a quaternary ammonium salt or a quaternary phosphonium salt dissolved in an organic solvent to create a new N-protected peptide or This is to obtain a lipophilic quaternary ammonium salt or quaternary phosphonium salt of the derivative.

又、有機溶媒としては、4級アンモニウム塩または4級
ホスホニウム塩を溶解し得てかつ水と均一に混和しない
もので出発物質及び目的生成物に特に活性なものでなけ
れば、いかなる溶媒も使用することが出来る。トルエン
、キシレン、ヘキサンのごとき炭化水素類、酢酸エチル
、酢酸ブチルのごときエステル類、クロロホルム、四塩
化炭素、エチレンジクロライドのごときハロダン化炭化
水素類、ブタノール、アミルアルコールのごときアルコ
ール類、メチルエチルケトンのごときケトン類、ジエチ
ルエーテル、ジインゾロビルエーテルのごときエーテル
類などが代表的なものであり、これらのうちの任意の2
種類以上からなる混合溶媒を使用することも出来る。
Further, as the organic solvent, any solvent can be used as long as it can dissolve the quaternary ammonium salt or the quaternary phosphonium salt, is not uniformly miscible with water, and is not particularly active for the starting material and the target product. I can do it. Hydrocarbons such as toluene, xylene, and hexane; esters such as ethyl acetate and butyl acetate; halodanized hydrocarbons such as chloroform, carbon tetrachloride, and ethylene dichloride; alcohols such as butanol and amyl alcohol; and ketones such as methyl ethyl ketone. Typical examples include ethers such as diethyl ether, diinzolovyl ether, etc., and any two of these
It is also possible to use a mixed solvent consisting of more than one type of solvent.

本発明の方法においてもちいられる酵素としては蛋白分
解酵素であれば特に制限はない。又、酵素反応を行々う
際の反応液の…は使用する酵素の種類により異なシ、例
えば、グロテアーゼM(大野製薬社製)及びオリエンタ
ーゼ5A(オリエンタル酵母社製)の場合は3〜7で、
サモアーゼ(大和化成社製)の場合は6〜8である。本
発明の酵素反応は温度10〜90℃、酵素活性を維持す
る観点からは20〜50℃で行なうとよい。
The enzyme used in the method of the present invention is not particularly limited as long as it is a proteolytic enzyme. In addition, the reaction solution when carrying out an enzyme reaction varies depending on the type of enzyme used, for example, 3 to 7 in the case of Grotease M (manufactured by Ohno Pharmaceutical Co., Ltd.) and Orientase 5A (manufactured by Oriental Yeast Co., Ltd.). in,
In the case of Samoase (manufactured by Daiwa Kasei Co., Ltd.), it is 6 to 8. The enzyme reaction of the present invention is preferably carried out at a temperature of 10 to 90°C, and from the viewpoint of maintaining enzyme activity, 20 to 50°C.

本発明の方法において、両出発物質の使用濃度には特に
制限はないが、ペプチド生成反応をより効率よく進行さ
せるためには、高い方が望ましい。
In the method of the present invention, there are no particular limitations on the concentrations of both starting materials used, but higher concentrations are desirable in order to allow the peptide production reaction to proceed more efficiently.

ペプチド生成反応を進行させるという観点からは、出発
物質の濃度が重要であって、両者の使用比率には特に制
限はない。
From the viewpoint of advancing the peptide production reaction, the concentration of the starting materials is important, and there is no particular restriction on the ratio of the two used.

本発明方法において用いられる4級アンモニウム塩ある
いはホスホニウム塩としては特に制限はなく、トリオク
チルメチルアンモニウムクロリド(ヘンケル社製A1.
1quat 336など)、セチルジメチルベンジルア
ンモニウムクロリド、テトラれ−ブチルホスホニウムブ
ロマイドなどが好適にもちいられる。又、その量は両出
発物質に対して多ければ多い程、目的生成物を有機溶媒
層に移行させ得るが、あまシ多すぎると酵素活性を低下
させる場合があるので、両出発物質の総量に対して0.
5〜5.0重量倍の比率でもちいられる。
There are no particular limitations on the quaternary ammonium salt or phosphonium salt used in the method of the present invention, including trioctylmethylammonium chloride (Henkel A1.
1quat 336, etc.), cetyldimethylbenzylammonium chloride, tetra-butylphosphonium bromide, and the like are preferably used. In addition, the larger the amount relative to both starting materials, the more the target product can be transferred to the organic solvent layer, but if it is too large, the enzyme activity may be reduced, so the total amount of both starting materials should be adjusted. Against 0.
It can be used at a ratio of 5 to 5.0 times by weight.

有機溶媒層に第4級アンモニウム塩またはホスホニウム
塩の形で移行したN−保護ペプチドまたはその誘導体を
分離回収するには、例えば、次のようにするとよい。4
級アンモニウム塩またはホスホニウム塩の形になったN
−保護ペプチドまたはその誘導体は例えば食塩水等と混
合することにより遊離させることができる。すなわち、
分離した有機溶媒層から食塩水で抽出すればよい。食塩
水の濃度は2〜20(重量)係がよい。
In order to separate and recover the N-protected peptide or its derivative transferred to the organic solvent layer in the form of a quaternary ammonium salt or phosphonium salt, the following may be performed, for example. 4
N in the form of ammonium or phosphonium salts
- The protected peptide or its derivative can be released, for example, by mixing with saline or the like. That is,
The separated organic solvent layer may be extracted with saline. The concentration of the saline solution is preferably between 2 and 20 (by weight).

以下、実施例、比較例により、本発明をさらに説明する
The present invention will be further explained below with reference to Examples and Comparative Examples.

実施例I N−アセチル−L−アスパラギン酸(以下、Ac−As
pと略記する。) 0.54 g (3,1mmot)
とL−フェニルアラニン(以下、Pheと略記する。)
0、1 g (0,6mmot)を適量の水に溶解し、
水酸化ナトリウム水溶液を加えてpH4,5に調整した
後、全体を5 mlにした。この水溶液にプロテアーゼ
M(大野製薬社製)50ダを添加した。完全に溶解させ
た後、トリオクチルメチルアンモニウムクロリド(A1
1quat 336 ) 1.25 g (3,1mm
ot)のトルエン溶液10m1を加え、40℃で24時
間振盪した。
Example I N-acetyl-L-aspartic acid (hereinafter referred to as Ac-As
It is abbreviated as p. ) 0.54 g (3.1 mmot)
and L-phenylalanine (hereinafter abbreviated as Phe)
Dissolve 0.1 g (0.6 mmot) in an appropriate amount of water,
After adjusting the pH to 4.5 by adding an aqueous sodium hydroxide solution, the total volume was made up to 5 ml. 50 Da of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, trioctylmethylammonium chloride (A1
1quat 336) 1.25 g (3.1mm
ot) was added to the mixture, and the mixture was shaken at 40°C for 24 hours.

反応液中(水層及びトルエン層)のAa−α−APを高
速液体クロマトグラフィー(以下、HPLCと略記する
。)にて定量したところ、Pb・に対して4.2係の収
率で生成していた(水層1.2%、)ルエン層3.0%
)。
When Aa-α-AP in the reaction solution (aqueous layer and toluene layer) was quantified using high-performance liquid chromatography (hereinafter abbreviated as HPLC), it was found that it was produced at a yield of 4.2% relative to Pb. (aqueous layer 1.2%,) luene layer 3.0%
).

実施例2 Ac−Aspo、 54 g (3,1mmot)とP
he O,1g (0,6mmot)を適量の水に溶解
し、水酸化ナトリウム水溶液を加えてpH4,5に調整
した後、全体を51nlにした。この水浴液にプロテア
ーゼM(大野製薬社製)501n9を添加した。完全に
溶解させた後、トリオクチルメチルアンモニウムクロリ
ド(A11quat336 ) 1.25 g (3,
1mmot)の四塩化炭素溶液lQmA!を加え、40
℃で24時間振盪した。
Example 2 Ac-Aspo, 54 g (3,1 mmot) and P
1 g (0.6 mmot) of heO was dissolved in an appropriate amount of water, the pH was adjusted to 4.5 by adding an aqueous sodium hydroxide solution, and the total volume was made up to 51 nl. Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) 501n9 was added to this water bath solution. After complete dissolution, add 1.25 g of trioctylmethylammonium chloride (A11quat336) (3,
1mmot) of carbon tetrachloride solution lQmA! Add 40
Shake at ℃ for 24 hours.

反応液中(水層及び四塩化炭素層)のAe−α−APを
、HPLCにて定量したところ、pheに対して4.3
俤の収率で生成していた(水1m 1.1%、四塩化炭
素層3.2%)。
When Ae-α-AP in the reaction solution (aqueous layer and carbon tetrachloride layer) was quantified by HPLC, it was 4.3% relative to phe.
It was produced at a yield of 1.1% (1 m of water, 3.2% carbon tetrachloride layer).

実施例3 Ac−Asp 0.54 g (3,1mmot)とP
he O,1g (0,6mmol )を適量の水に溶
解し、水酸化ナトリウム水溶液を加えてpH4,5に調
整した後、全体を5mA’にした。この水溶液にプロテ
アーゼM(大野製薬社製)50m9を添加した。完全に
溶解させた後、セチルジメチルベンジルアンモニウムク
ロリド1.23g (3,1mmot)のりo o ホ
にム溶液10mlヲ加j’L、40℃で24時間振盪し
た。
Example 3 Ac-Asp 0.54 g (3.1 mmot) and P
1 g (0.6 mmol) of heO was dissolved in an appropriate amount of water, the pH was adjusted to 4.5 by adding an aqueous sodium hydroxide solution, and the total was brought to 5 mA'. 50 m9 of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, 1.23 g (3.1 mmot) of cetyldimethylbenzyl ammonium chloride was added to 10 ml of a homogeneous solution, and the mixture was shaken at 40° C. for 24 hours.

反応液中(水層及びクロロホルム層)のAe−α−AP
を、HPLCにて定量したところ、l’?heに対して
4.2係の収率で生成していた(水層1.2 % 、ク
ロロホルム層3.0係)。
Ae-α-AP in the reaction solution (aqueous layer and chloroform layer)
When quantified by HPLC, l'? It was produced at a yield of 4.2 parts based on he (aqueous layer 1.2%, chloroform layer 3.0 parts).

実施例4 Ae−Asp 0.54 g (3,1rrrnot 
)とpbs 0.1 g (0,6mmot)を適量の
水に溶解し、水酸化ナトリウム水溶液を加えてpH4,
5に調整した後、全体を5 mlにした。この水溶液に
プロテアーゼM(大野製薬社製)50叩を添加した。完
全に溶解させた後、テトラn−ブチルホスホニウムブロ
マイド1.05 g(3,1mmot )の1,2−ジ
クロルエタン溶液10mを加え、40℃で24時間振盪
した。
Example 4 Ae-Asp 0.54 g (3,1rrrnot
) and PBS 0.1 g (0.6 mmot) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting the volume to 5 ml, the total volume was adjusted to 5 ml. 50 doses of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, 10 m of a solution of 1.05 g (3,1 mmot) of tetra n-butylphosphonium bromide in 1,2-dichloroethane was added, and the mixture was shaken at 40°C for 24 hours.

反応液中(水層及び1.2−ジクロルエタン層)のAe
−α−APを、)(PLCにて定量したところ、Phe
に対して3.1係の収率で生成していた(水層1,6チ
、l、2−ジクロルエタン層1.5 qb)。
Ae in the reaction solution (aqueous layer and 1,2-dichloroethane layer)
-α-AP was quantified by PLC.
The product was produced at a yield of 3.1 compared to that of the aqueous layer (1.6 qb of aqueous layer, 1.5 qb of l,2-dichloroethane layer).

比較例1(実施例1〜5に対する比較例)Ac−Asp
 0.54 g (3,1mmot )とPhe 0.
1 g (0,6mmoL )を適量の水に溶解し、水
酸化ナトリウム水溶液を加えてpH4,5K調整した後
、全体を5dにした。この水溶液にプロテアーゼM(大
野製薬社製)50rn9を添加した。完全に溶解させた
後、40℃で24時間振盪した。
Comparative Example 1 (Comparative Example for Examples 1 to 5) Ac-Asp
0.54 g (3,1 mmot) and Phe 0.
1 g (0.6 mmol) was dissolved in an appropriate amount of water, and after adjusting the pH to 4.5 K by adding an aqueous sodium hydroxide solution, the total pH was adjusted to 5 d. Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) 50rn9 was added to this aqueous solution. After complete dissolution, it was shaken at 40°C for 24 hours.

水液中のAc−α−APをHPLCにて定量したところ
、pheに対して1.6チの収率で生成していた。
When Ac-α-AP in the aqueous solution was quantified by HPLC, it was found to be produced at a yield of 1.6% based on phe.

実施例5 Ae−Asp 2.17 g (12,4mmot)と
Phe 0.1 g (0,6mmot)を適量の水に
溶解し、水酸化ナトリウム水溶液を加えて−4,5に調
整した後、全体を54忙した。この水溶液にプロテアー
ゼM(大野製薬社製)50■を添加した。完全に溶解さ
せた後、トリオクチルメチルアンモニウムクロリド(A
11quat336 ) 1.25 g (3,1mr
not)のトルエン溶液10ゴを加え、40℃で44時
間振盪した。
Example 5 2.17 g (12.4 mmot) of Ae-Asp and 0.1 g (0.6 mmot) of Phe were dissolved in an appropriate amount of water, and after adjusting to -4.5 by adding an aqueous sodium hydroxide solution, The whole thing was 54 busy. 50 μm of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, trioctylmethylammonium chloride (A
11quat336) 1.25g (3.1mr
10 g of a toluene solution of (not) was added, and the mixture was shaken at 40°C for 44 hours.

反応液中(水層及びトルエン層)のAe−α−APを、
I(PLCにて定量したところ、pbeに対して11.
1チの収率で生成していた(水層3.3%、)ルエン八
47.8  係  ) 。
Ae-α-AP in the reaction solution (aqueous layer and toluene layer),
I (quantified by PLC, 11.
It was produced at a yield of 1.1% (aqueous layer: 3.3%, luene: 47.8%).

実施例6 Ac−Asp 2.17 g (12,4mmot)と
Phe O,1g(0,6mmol )を適量の水に溶
解し、水酸化ナトリウム水浴液を加えてPll 4.5
に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(大野製薬社製) 50m9を添加した。完
全に溶解させた後、トリオクチルメチルアンモニウムク
ロリド(A11quat336 ) 1.25 g (
3,1mmot)のトルエン/ヘキサン(1/1)溶液
104を加え、40℃で44時間振盪した。
Example 6 Ac-Asp 2.17 g (12.4 mmot) and Phe O, 1 g (0.6 mmol) were dissolved in an appropriate amount of water, and a sodium hydroxide water bath solution was added to give a Pll of 4.5
After adjusting to 5 ml, the total volume was adjusted to 5 ml. 50m9 of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After completely dissolving, add 1.25 g of trioctylmethylammonium chloride (A11quat336) (
A toluene/hexane (1/1) solution 104 of 3.1 mmot) was added, and the mixture was shaken at 40° C. for 44 hours.

反応液中(水層及びトルエン/ヘキサン層)のAc−α
−APを、)(PLCにて定量したところ、Rhoに対
して11.0%の収率で生成していた(水層3.1係、
トルエン/ヘキサン層7.9%)。
Ac-α in the reaction solution (aqueous layer and toluene/hexane layer)
-AP was quantified by PLC, and it was found that it was produced at a yield of 11.0% relative to Rho (aqueous layer 3.1 section,
toluene/hexane layer 7.9%).

実施例7 Ac−Asp 2.17 g (12,4mmot)と
phe 0.1 g (0,6mmot)を適量の水に
溶解し、水酸化ナトリウム水溶液を加えて一■4.5に
調整した後、全体を5mlにした。この水溶液にプロテ
アーゼM(大野製薬社製)50■を添加した。完全に溶
解させた後、セチルジメチルベンジルアンモニウムクロ
リド2.46g (6,2mmot)のクロロホルム溶
液20rnlを加え、40℃で44時間振盪した。
Example 7 Ac-Asp 2.17 g (12.4 mmot) and phe 0.1 g (0.6 mmot) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the concentration to 4.5 mm. , the total volume was 5 ml. 50 μm of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, 20 rnl of a chloroform solution of 2.46 g (6.2 mmot) of cetyldimethylbenzyl ammonium chloride was added, and the mixture was shaken at 40° C. for 44 hours.

反応液中(水層及びクロロホルム層)のAe−α−AP
を、HPLC[て定量したところ、Pheに対して20
、11の収率で生成していた(水層5.1%、クロロホ
ルム層15.0%)。
Ae-α-AP in the reaction solution (aqueous layer and chloroform layer)
was quantified by HPLC [20
, with a yield of 11 (aqueous layer 5.1%, chloroform layer 15.0%).

比較例2(実施例5〜7に対する比較例)Ae−Asp
 2.17 g (12,4mmot)とPh@0.1
g(0,6mmot )を適量の水に溶解し、水酸化ナ
トリウム水浴液を加えてPH4,5に調整した後、全体
を5 mlにした。この水溶液にプロテアーゼM(大野
製薬社製)50!n9を添加した。完全に溶解させた後
、40℃で44時間振盪した。
Comparative Example 2 (Comparative Example for Examples 5 to 7) Ae-Asp
2.17 g (12,4 mmot) and Ph@0.1
g (0.6 mmot) was dissolved in an appropriate amount of water, the pH was adjusted to 4.5 by adding sodium hydroxide water bath solution, and the total volume was made up to 5 ml. Add 50% of Protease M (manufactured by Ohno Pharmaceutical) to this aqueous solution. n9 was added. After complete dissolution, it was shaken at 40°C for 44 hours.

水液中のAc−α−APをHPLCにて定量したところ
、Pheに対して5.2チの収率で生成していた。
When Ac-α-AP in the aqueous solution was quantified by HPLC, it was found to be produced at a yield of 5.2% based on Phe.

実施例8 Ac−Asp 0.54 g (3,1rr1rrIo
t)とPh s O,1g (0,6mmot)を適量
の水に溶解し、水酸化ナトリウム水溶液を加えて−I4
.5に調整した後、全体を5 ml K L、た。
Example 8 Ac-Asp 0.54 g (3,1rr1rrIo
t) and Ph s O, 1 g (0.6 mmot) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to prepare -I4.
.. After adjusting to 5, the total volume was 5 ml KL.

この水溶液にプロテアーゼM(大野製薬社製)200ダ
を添加した。完全に溶解させた後、トリオクチルメチル
アンモニウムクロリド(A11quat336 ) 1
.25 g (3,1mmot )のトルエン溶液10
mA’を加え、40℃で48時間振盪した。
200 Da of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After completely dissolving, trioctylmethylammonium chloride (A11quat336) 1
.. 25 g (3,1 mmot) of toluene solution 10
mA' was added and shaken at 40°C for 48 hours.

反応液中(水層及びトルエン層)のAC−α−APを、
HPLCにて定量したところ、Rhoに対して5.0チ
の収率で生成していた(水層1.5%、)ルエン層3.
5チ)。
AC-α-AP in the reaction solution (aqueous layer and toluene layer),
When quantified by HPLC, it was found that the toluene layer was produced at a yield of 5.0% based on Rho (aqueous layer: 1.5%).
5chi).

実施例9 Aa−Asp 0.54g(3,1mmot)とPh 
e 0.1 g (0,6rrvnol)を適量の水に
溶解し、水酸化す) IJウム水溶液を加えてp+(3
,0に調整した後、全体を5ゴにした。
Example 9 Aa-Asp 0.54 g (3.1 mmot) and Ph
Dissolve 0.1 g (0.6 rrvnol) in an appropriate amount of water and hydroxylate)
, After adjusting to 0, the whole was set to 5.

この水溶液にプロテアーゼM(大野製薬社製)50■を
添加した。完全に溶解させた後、トリオクチルメチルア
ンモニウムクロリド(A11quat336)1.25
g(3,1mmot)のトルエン溶液10m/を加え、
40℃で22時間振盪した。
50 μm of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, trioctylmethylammonium chloride (A11quat336) 1.25
Add 10 m/g (3,1 mmot) of toluene solution,
It was shaken at 40°C for 22 hours.

反応液中(水層及びトルエン層)のAe−α−APを、
HPLCにて定置したところ、:’Pheに対して3.
4係の収率で生成していた(水層09%、トルエン層2
5チ)。
Ae-α-AP in the reaction solution (aqueous layer and toluene layer),
When fixed in HPLC, 3.
It was produced with a yield of 4% (aqueous layer 09%, toluene layer 2%).
5chi).

実施例10 Aa−Asp O,54g (3,1mmot)とPh
e 0.1 g (0,6mmot)を適量の水に溶解
し、水酸化す) IJウム水溶液を加えて−4,5に調
整した後、全体を5mlにした。この水溶液にプロテア
ーゼM(大野製薬社製)5o+yを添加した。完全に溶
解させた後、トリオクチルメチルアンモニウムクロリド
(Aliquat 336 ) 1.25 g (3,
1mmot)のトルエン溶液IQm/を加え、25℃で
96時間振盪した。
Example 10 Aa-Asp O, 54g (3.1 mmot) and Ph
0.1 g (0.6 mmot) was dissolved in an appropriate amount of water and hydroxylated. After adjusting to -4.5 by adding an aqueous solution of IJ, the total volume was made up to 5 ml. Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) 5o+y was added to this aqueous solution. After complete dissolution, 1.25 g trioctylmethylammonium chloride (Aliquat 336) (3,
1 mmot) of toluene solution IQm/ was added, and the mixture was shaken at 25° C. for 96 hours.

反応液中(水層及びトルエン層)のAe−α−APを、
HPLICて定量したところ、pheに対して4.0係
の収率で生成していた(水層1.2%、トルエン層2.
8チ)。
Ae-α-AP in the reaction solution (aqueous layer and toluene layer),
When quantified using HPLIC, it was found that phe was produced at a yield of 4.0% (aqueous layer: 1.2%, toluene layer: 2.0%).
8chi).

実施例11 N−ホルミル−L−アスノ9ラギン酸(以下、For−
Aspと略記する。  ) 0.5 g (3,1mm
ol)とPie O,1g (0,6mmot)を適量
の水に溶解し、水酸化す) IJウム水溶液を加えてP
H4,5に調整した後、全体を5Hにした。この水溶液
にプロテアーゼM(天野製薬社製)507Qを添加した
。完全に溶解された後、トリオクチルメチルアンモニウ
ムクロリド(A11quat 336 ) 1.25 
g (3,1rrmot)のトルエン溶液Ion/を加
え、40℃で72時間振盪した。
Example 11 N-formyl-L-asno9ragic acid (hereinafter referred to as For-
It is abbreviated as Asp. ) 0.5 g (3.1mm
P
After adjusting to H4 and 5, the whole was set to 5H. Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) 507Q was added to this aqueous solution. After completely dissolved, trioctylmethylammonium chloride (A11quat 336) 1.25
A toluene solution of Ion/g (3,1rrmot) was added and the mixture was shaken at 40°C for 72 hours.

反応液中(水層及びトルエン層)のN−ホルミル−α−
L−アスノ9ルチルーL−7エニルアラニン(以下、F
or−α−APと略記する。)をHPLCにて定量した
ところ、Ph・に対して2.9俤の収率で生成していた
(水層0.7%、トルエン層2.2 % )。
N-formyl-α- in the reaction solution (aqueous layer and toluene layer)
L-asuno9rutile-L-7enylalanine (hereinafter referred to as F
It is abbreviated as or-α-AP. ) was quantified by HPLC, and it was found that it was produced in a yield of 2.9 yen based on Ph. (0.7% in water layer, 2.2% in toluene layer).

比較例3(実施例11に対する比較例)For−Asp
 0.5 g (3,1mmot)とPhe 0.1g
 (0,6mmot)を適量の水に溶解し、水酸化ナト
リウム水溶液を加えてpH4,5に調整した後、全体を
5−にした。この水溶液にプロテアーゼM(天野製薬社
製)501n9を添加した。完全に溶解させた後、40
℃で72時間振盪した。
Comparative Example 3 (Comparative Example with respect to Example 11) For-Asp
0.5 g (3,1 mmot) and Phe 0.1 g
(0.6 mmot) was dissolved in an appropriate amount of water, the pH was adjusted to 4.5 by adding an aqueous sodium hydroxide solution, and the whole was adjusted to 5-. Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) 501n9 was added to this aqueous solution. After completely dissolving, 40
Shake for 72 hours at °C.

水液中のF’or−α−APをHPI、Cにて定量した
ところ、pheに対して0.8%の収率で生成していた
When F'or-α-AP in the aqueous solution was quantified using HPI, C, it was found that it was produced at a yield of 0.8% based on phe.

実施例12 For−Asp 2. Og (12,4mmoL )
とphaQ、1g(0,6mmot)を適量の水に溶解
し、水酸化ナトリウム水溶液を加えてp)14.5に調
整した後、全体を5 mlにした。この水溶液にプロテ
アーゼM(天野製薬社製)50■を添加した。完全に溶
解させた後、トリオクチルメチルアンモニウムクロリド
(A11quat 336 ) 1.25 g (3,
1mmot)のトルエン溶液IQmlを加え、40℃で
76時間振盪した。
Example 12 For-Asp 2. Og (12,4 mmol)
and phaQ, 1 g (0.6 mmot) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the p) to 14.5, and the total volume was made up to 5 ml. 50 μm of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, add 1.25 g of trioctylmethylammonium chloride (A11quat 336) (3,
IQml of a toluene solution of 1 mmot) was added, and the mixture was shaken at 40°C for 76 hours.

反応液中(水層及びトルエン層)のFor−α−APを
HPLCにて定量したところ、Pheに対して6,3%
の収率で生成していた(水層2.om、)ルエン層4.
3チ)。
When For-α-AP in the reaction solution (aqueous layer and toluene layer) was quantified by HPLC, it was found to be 6.3% relative to Phe.
The toluene layer was produced at a yield of 2.0m (aqueous layer 2.0m).
3chi).

実施例13 For−Asp 0.5 g  (3,1rnmot)
とP・he 0.1 g (0,6mmot)を適量の
水に溶解し、水酸化ナトリウム水溶液を加えてpH4,
5に調整した後、全体を5dにした。この水溶液にオリ
エンターゼ5A(オリエンタル酵母社製)50rII9
を添加した。完全に溶解させた後、トリオクチルメチル
アンモニウムクロリド(A11quat 336 ) 
1.25 g (3,1mmot)の酢酸エチル溶液1
01117を加え、40℃で71時間振盪した。
Example 13 For-Asp 0.5 g (3,1rnmot)
and P.he 0.1 g (0.6 mmot) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the whole was set to 5d. Add orientase 5A (manufactured by Oriental Yeast Co., Ltd.) 50rII9 to this aqueous solution.
was added. After complete dissolution, trioctylmethylammonium chloride (A11quat 336)
1.25 g (3.1 mmot) of ethyl acetate solution 1
01117 was added and shaken at 40°C for 71 hours.

反応液中(水層及び酢酸エチル層)のFor−α−AP
をHPLCにて定量したところ、Pheに対して1.1
%の収率で生成していた(水層0.3 % 、酢酸エチ
ル層0.8係)。
For-α-AP in the reaction solution (aqueous layer and ethyl acetate layer)
When quantified by HPLC, it was found to be 1.1 with respect to Phe.
% yield (aqueous layer 0.3%, ethyl acetate layer 0.8%).

比較例4(実施例13に対する比較例)For−Asp
 0.5 g (3,1mmot )とphe o、 
1 g(0,6mmot)を適量の水に溶解し、水酸化
す) IJウム水溶液を加えてPH4,5に調整した後
、全体を5−にした。この水溶液にオリエンターゼ5A
(オリエンタル酵母社#)50■を添加した。完全に溶
解させた後、40℃で71時間振盪した。
Comparative Example 4 (Comparative Example to Example 13) For-Asp
0.5 g (3,1 mmot) and phe o,
After dissolving 1 g (0.6 mmot) in an appropriate amount of water and hydrating it, the pH was adjusted to 4.5 by adding an aqueous IJ solution, and the whole was adjusted to 5-. Add orientase 5A to this aqueous solution.
(Oriental Yeast Co., Ltd. #) 50μ was added. After complete dissolution, it was shaken at 40°C for 71 hours.

水液中のFor−α−APをHPLCにて定量したとこ
ろ、Phaに対して0.4 %の収率で生成していた。
When For-α-AP in the aqueous solution was quantified by HPLC, it was found to be produced at a yield of 0.4% based on Pha.

実施例14 N−ホルミル−L−アスパラギン酸−α−メチルエステ
ル(以下、For−A@p−OMeと略記する。)0、
54 g (3,1mmot)とP+h* 0.1 g
 (0,6mmot)を適量の水に溶解し、水酸化ナト
リウム水溶液を加えてpH4,5に調整した後、全体を
51111にした。
Example 14 N-formyl-L-aspartic acid-α-methyl ester (hereinafter abbreviated as For-A@p-OMe) 0,
54 g (3,1 mmot) and P+h* 0.1 g
(0.6 mmot) was dissolved in an appropriate amount of water, the pH was adjusted to 4.5 by adding an aqueous sodium hydroxide solution, and the total pH was adjusted to 51111.

この水溶液にプロテアーゼM(天野製薬社製)50Tn
9を添加した。完全に溶解させた後、トリオクチルメチ
ルアンモニウムクロリド(A11quat336 ) 
1.25 g (3,1ramot)のトルエン溶液I
Qmlを加え、40℃で65時間振盪した。
Add Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) 50Tn to this aqueous solution.
9 was added. After complete dissolution, trioctylmethylammonium chloride (A11quat336)
1.25 g (3,1 ramot) of toluene solution I
Qml was added and shaken at 40°C for 65 hours.

反応液中(水層及びトルエン層)のFor−α−APを
HPLCにて定量したところ、Pheに対して7.2%
の収率で生成していた(水層1.9%、)ルエン層5.
3係)。
For-α-AP in the reaction solution (aqueous layer and toluene layer) was quantified by HPLC and found to be 7.2% relative to Phe.
The toluene layer was produced at a yield of 5. (aqueous layer 1.9%).
Section 3).

比較例5(実施例14に対する比較例)For−Asp
 −OMe O,54g (3,1mmot)とPhe
 O,1g (0,6mmot)を適量の水に溶解し、
水酸化ナトリウム水溶液を加えてpH4,5K調整した
後、全体を5Hにした。この水溶液にプロテアーゼM(
天野製薬社製)50■を添加した。完全に溶解させた後
、40℃で65時間振盪した。
Comparative Example 5 (Comparative Example to Example 14) For-Asp
-OMe O, 54g (3,1 mmot) and Phe
Dissolve O.1g (0.6mmot) in an appropriate amount of water,
After adjusting the pH to 4.5K by adding an aqueous sodium hydroxide solution, the entire solution was brought to 5H. Protease M (
50 μm (manufactured by Amano Pharmaceutical Co., Ltd.) was added. After complete dissolution, it was shaken at 40°C for 65 hours.

水液中のFor−α−APをHPLCにて定量したとこ
ろ、Pbeに対して2.1%の収率で生成していた。
When For-α-AP in the aqueous solution was quantified by HPLC, it was found to be produced at a yield of 2.1% based on Pbe.

実施例15 11J、、ベンジルオキシカルがニルーL−7スノ母う
キン酸(以下、Z−Aspと略記する。) 0.83 
g(3,1mmot)とPhs 0.1 g (0,6
mmot)を適量の水に溶解し、水酸化す) IJウム
水溶液を加えて−14、5 K調整した後、全体を5 
alにした。この水溶液にプロテアーゼM(大野製薬社
製)50Tn9を添加した。完全に溶解させた後、トリ
オクチルメチルアンモニウムクロリド(A11quat
 336 )1.25g (3,1mmot)のトルエ
ン溶液10m1を加え、40℃で44時間振盪した。
Example 15 11J, benzyloxycarboxylic acid (hereinafter abbreviated as Z-Asp) 0.83
g (3,1 mmot) and Phs 0.1 g (0,6
After adjusting the temperature to -14.5 K by adding an aqueous IJ solution, the whole solution was heated to 5 K.
I changed it to al. Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) 50Tn9 was added to this aqueous solution. After complete dissolution, trioctylmethylammonium chloride (A11quat
336) 10 ml of a toluene solution of 1.25 g (3.1 mmot) was added and shaken at 40° C. for 44 hours.

反応液中(水層及びトルエン層)のN−ベンジルオキシ
カルボニル−α−L−アス/4’ルチルーL−7エニル
アラニン(以下、2−α−APと略記する。)をHPL
Cにて定量したところ、Pheに対して8.1%の収率
で生成していた(水層1.1%、トルエン層7.0係)
N-benzyloxycarbonyl-α-L-as/4'rutile-L-7enylalanine (hereinafter abbreviated as 2-α-AP) in the reaction solution (aqueous layer and toluene layer) was analyzed by HPL.
When quantified at C, it was found that it was produced at a yield of 8.1% based on Phe (aqueous layer 1.1%, toluene layer 7.0%)
.

比較例6(実施例15に対する比較例)Z−Asp 0
.83 g (3,1mmot)とPhe 0.1 g
(0,6mmot)を適量の水に溶解し、水酸化ナトリ
ウム水溶液を加えてpl(4,5に調整した後、全体を
5 rnlにした。この水溶液にプロテアーゼM(大野
製薬社製)50rn9を添加した。完全に溶解させた後
、49℃で44時間振盪した。
Comparative Example 6 (Comparative Example to Example 15) Z-Asp 0
.. 83 g (3,1 mmot) and Phe 0.1 g
(0.6 mmot) was dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pl (4.5), and the total volume was then adjusted to 5 rnl. Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) 50rn9 was added to this aqueous solution. After complete dissolution, it was shaken at 49°C for 44 hours.

水液中の2−α−APをHPLCにて定量したところ、
Pbsに対して2.4%の収率で生成していた。
When 2-α-AP in aqueous solution was quantified by HPLC,
It was produced at a yield of 2.4% based on Pbs.

実施例16 Z−Asp 0.67 g (2,5mmot)とL−
フz−”ルアラニンメチルエステル(以下、PMと略記
する。)0、45 g (2,5mmot)を適量の水
に溶解し、水酸化ナトリウム水溶液を加えてpH6,2
に調整した後、全体を18mA!にした。この水溶液に
サモアーゼ(大和化成社製)120〜を添加した。完全
に溶解させた後、トリオクチルメチルアンモニウムクロ
リド(A11quat 336 ) 2.06 g (
5,1mmot)のトルエン溶液207dを加え、40
℃で3時間振盪した。
Example 16 Z-Asp 0.67 g (2.5 mmot) and L-
Dissolve 0.45 g (2.5 mmot) of Fz-''lualanine methyl ester (hereinafter abbreviated as PM) in an appropriate amount of water, and adjust the pH to 6.2 by adding an aqueous sodium hydroxide solution.
After adjusting to 18mA overall! I made it. Samoase (manufactured by Daiwa Kasei Co., Ltd.) 120~ was added to this aqueous solution. After complete dissolution, 2.06 g of trioctylmethylammonium chloride (A11quat 336) (
Add 207 d of toluene solution of 5.1 mmot),
It was shaken at ℃ for 3 hours.

反応液中(水層及びトルエン層)のN−ベンジルオキシ
カルボニル−α−L−フェニルアラニンメチルエステル
(以下、2−α−APMと略記する。)をHPLCにて
定量したところ、Pheに対して54.6係の収率で生
成していた(水層18.0%、)ルエン層36.6 %
 )。
When N-benzyloxycarbonyl-α-L-phenylalanine methyl ester (hereinafter abbreviated as 2-α-APM) in the reaction solution (aqueous layer and toluene layer) was quantified by HPLC, it was found to be 54% relative to Phe. The yield of .6 was produced (aqueous layer 18.0%), toluene layer 36.6%
).

比較例7(実施例16に対する比較例)Z−Asp 0
.67 g (2゜5 mmot)とPMo、45g(
2,5mmot)を適量の水に溶解し、水酸化す) I
Jウム水溶液を加えてpH6,2に調整した後、全体を
181mにした。この水溶液にサモアーゼ(大和化成社
製)120Tn9を添加した。完全に溶解させた後、4
0℃で3時間振盪した。
Comparative Example 7 (Comparative Example to Example 16) Z-Asp 0
.. 67 g (2°5 mmot) and PMo, 45 g (
Dissolve 2.5 mmot) in an appropriate amount of water and hydroxylate) I
After adjusting the pH to 6.2 by adding a Jium aqueous solution, the total volume was adjusted to 181 m. Samoase (manufactured by Daiwa Kasei Co., Ltd.) 120Tn9 was added to this aqueous solution. After completely dissolving, 4
It was shaken at 0°C for 3 hours.

水液中の2−α−APMをHPI、Cにて定量したとこ
ろ、Pheに対して19.44の収率で生成していた。
When 2-α-APM in the aqueous solution was quantified by HPI, C, it was found to be produced at a yield of 19.44 based on Phe.

実施例17 N−アセチル−L−アラニン(以下、Aa −Ataと
略記する。) 0.4 g (3,0mmot)とI、
−ロイシン(以下、L@uと略記する* 0.08 g
 (0,6mmot)を適量の水に溶解し、水酸化す)
 IJウム水溶液を加えてpH44,5に調整した後、
全体を5. Q mlにした。この水溶液にプロテアー
ゼM(大野製薬社製)50rvを添加した。完全に溶解
させた後、トリオクチルメチルアンモニウムクロリド(
A11quat336)1、22 g (3,0mmo
t)のトルエン溶液10m1!を加え、40℃で49時
間振盪した。
Example 17 N-acetyl-L-alanine (hereinafter abbreviated as Aa-Ata) 0.4 g (3.0 mmot) and I,
-Leucine (hereinafter abbreviated as L@u* 0.08 g
(0.6 mmot) is dissolved in an appropriate amount of water and hydroxylated)
After adjusting the pH to 44.5 by adding IJum aqueous solution,
Overall 5. Q: I changed it to ml. 50 rv of Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) was added to this aqueous solution. After complete dissolution, add trioctylmethylammonium chloride (
A11quat336) 1,22 g (3,0 mmo
t) toluene solution 10ml! was added and shaken at 40°C for 49 hours.

反応液中(水層及びトルエン層)のAc−Ala−Le
uをHPLCにて定量したととる、Le+1に対して2
.3係の収率で生成していた(水層0.6%、トルエン
層1.7%)。
Ac-Ala-Le in the reaction solution (aqueous layer and toluene layer)
Assuming that u was quantified by HPLC, 2 for Le+1
.. It was produced at a yield of 3% (aqueous layer 0.6%, toluene layer 1.7%).

比較例8(実施例17に対する比較例)Aa−A、la
 0.4 g (3,0mmot)とLsu 0.08
g(0,6mmot)を適量の水に溶解し、水酸化ナト
リウム水溶液を加えてpT(4,5に調整した後、全体
を5tnlにした。この水溶液にプロテアーゼM(大野
製薬社製)50■を添加した。完全に溶解させた後、4
0℃で49時間振盪した。
Comparative example 8 (comparative example to Example 17) Aa-A, la
0.4 g (3,0 mmot) and Lsu 0.08
g (0.6 mmot) was dissolved in an appropriate amount of water, the pT was adjusted to 4.5 by adding an aqueous sodium hydroxide solution, and the total volume was made up to 5 tnl.Protease M (manufactured by Ohno Pharmaceutical Co., Ltd.) 50 μm was added to this aqueous solution. After complete dissolution, 4
Shake at 0°C for 49 hours.

水液中のAe−Ara−LsuをHPLCにて定量した
ところ、Leaに対して0.71の収率で生成していた
When Ae-Ara-Lsu in the aqueous solution was quantified by HPLC, it was found to be produced at a yield of 0.71 relative to Lea.

実施例18 比較例3と同様に反応させて得られたFor−Asp2
.5 g 、 For−α−AP0.009g及びL 
−PheO05gを含む酵素反応液25rnlにトリオ
クチルメチルアンモニウムクロリド6、25 gのトル
エン溶液50tnlを加え、PHを6.0に調整した後
、37℃で15分間振盪した。
Example 18 For-Asp2 obtained by reacting in the same manner as Comparative Example 3
.. 5 g, For-α-AP 0.009 g and L
50 tnl of a toluene solution containing 6.25 g of trioctylmethylammonium chloride was added to 25 rnl of the enzyme reaction solution containing 05 g of -PheO, the pH was adjusted to 6.0, and the mixture was shaken at 37°C for 15 minutes.

トルエン層を分離し、For−Asp 、 For−α
−AP及びL −Ph・をHPI、Cにて定量したとこ
ろ、トルエン層中にF’or−α−APFi76 %抽
出されていた。
Separate the toluene layer, For-Asp, For-α
-AP and L-Ph. were quantified by HPI and C, and it was found that 76% of F'or-α-APFi was extracted in the toluene layer.

一方、For−Asp、Pheは、それぞれ、9%、7
%抽出されたにすぎなかった。因みに、F’or−α−
AP。
On the other hand, For-Asp and Phe were 9% and 7%, respectively.
Only % was extracted. By the way, F'or-α-
A.P.

For−Asp及びPheの水−トルエン間の分配係数
は、それぞれ、1.35,0.04,0.03であった
The water-toluene partition coefficients of For-Asp and Phe were 1.35, 0.04, and 0.03, respectively.

比較例9(実施例18に対する比較例)トリオクチルメ
チルアンモニウムクロリドを添加しない以外は、実施例
18と同様の実験を行なったところ、For−α−AP
はトルエン層中に全く抽出されず、その分配係数は0で
あった。
Comparative Example 9 (Comparative Example to Example 18) An experiment similar to Example 18 was conducted except that trioctylmethylammonium chloride was not added.
was not extracted into the toluene layer at all, and its partition coefficient was 0.

実施例19 比較例1と同様に反応して得られたAc−Asp 2.
6g +Ae−α−AP0.015g及びPhe O,
5gを含む酵素反応液25m1VCトリオクチルメチル
アンモニウムクロリド6.25gのトルエン溶液50m
Aを加え、−■を4.4に調整した後、37℃で15分
間振盪した。
Example 19 Ac-Asp obtained by reacting in the same manner as Comparative Example 1 2.
6g + Ae-α-AP0.015g and Phe O,
25ml of enzyme reaction solution containing 5g VC trioctylmethylammonium chloride 6.25g of toluene solution 50ml
After adding A and adjusting -■ to 4.4, the mixture was shaken at 37°C for 15 minutes.

トルエン層を分離し、Ac−Asp * Ac−α−A
P及(J L −PbeをT(PLCにて定量したとこ
ろ、トルエン層中にAc−α−APは63係抽出されて
いた。一方、Ac−Asp 、 Pheは、それぞれ、
9係、2係抽出されたにすぎなかった。因みに、AC−
α−AP。
Separate the toluene layer and prepare Ac-Asp*Ac-α-A
When P and (J L -Pbe were quantified by T (PLC), 63% of Ac-α-AP was extracted in the toluene layer. On the other hand, Ac-Asp and Phe were
Only 9 sections and 2 sections were extracted. By the way, AC-
α-AP.

Ac−Asp及びL −Pheの水−トルエン間の分配
係数は、それぞれ、1.03,0.07,0.01であ
った。
The water-toluene partition coefficients of Ac-Asp and L-Phe were 1.03, 0.07, and 0.01, respectively.

比較例10(実施例19に対する比較例)トリオクチル
メチルアンモニウムクロリドを添加しない以外は、実施
例19と同様の実験を行なったところ、Ac−α−AP
はトルエン層中に全く抽出されず、その分配係数はOで
あった。
Comparative Example 10 (Comparative Example to Example 19) An experiment similar to Example 19 was conducted except that trioctylmethylammonium chloride was not added.
was not extracted into the toluene layer at all, and its partition coefficient was O.

Claims (2)

【特許請求の範囲】[Claims] (1)N−保護アミノ酸またはその誘導体とアミノ酸ま
たはその誘導体とを、4級アンモニウム塩または4級ホ
スホニウム塩を溶解した水非混和性有機溶媒と水との2
相系反応媒体中において水層で蛋白分解酵素を用いて反
応させ、生成した少くとも1つのカルボキシル基をもつ
N−保護ペプチドを親油性の4級アンモニウム塩または
4級ホスホニウム塩として有機溶媒相に移行させること
を特徴とするN−保護ペプチドまたはその誘導体の酵素
的合成法。
(1) N-protected amino acid or its derivative and amino acid or its derivative are mixed with water and a water-immiscible organic solvent in which a quaternary ammonium salt or quaternary phosphonium salt is dissolved.
The reaction is carried out using a proteolytic enzyme in the aqueous phase in a phase-based reaction medium, and the resulting N-protected peptide having at least one carboxyl group is transferred to the organic solvent phase as a lipophilic quaternary ammonium salt or quaternary phosphonium salt. 1. A method for enzymatic synthesis of N-protected peptides or derivatives thereof, which is characterized by translocation.
(2)N−保護アミノ酸またはその誘導体とアミノ酸ま
たはその誘導体とを水中で蛋白分解酵素を用いて反応さ
せ、生成した少くとも1つのカルボキシル基をもつN−
保護ペプチドを4級アンモニウム塩または4級ホスホニ
ウム塩を溶解した水非混和性有機溶媒で抽出回収するこ
とを特徴とするN−保護ペプチドまたはその誘導体の酵
素的合成法。
(2) The N-protected amino acid or its derivative is reacted with the amino acid or its derivative in water using a protease, and the resulting N-
1. A method for enzymatically synthesizing an N-protected peptide or a derivative thereof, which comprises extracting and recovering the protected peptide with a water-immiscible organic solvent in which a quaternary ammonium salt or a quaternary phosphonium salt is dissolved.
JP10431986A 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides Expired - Lifetime JPH0634745B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10431986A JPH0634745B2 (en) 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10431986A JPH0634745B2 (en) 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides

Publications (2)

Publication Number Publication Date
JPS62259597A true JPS62259597A (en) 1987-11-11
JPH0634745B2 JPH0634745B2 (en) 1994-05-11

Family

ID=14377613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10431986A Expired - Lifetime JPH0634745B2 (en) 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides

Country Status (1)

Country Link
JP (1) JPH0634745B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502165A (en) * 1994-04-04 1996-03-26 Merck & Co., Inc. Process for peptide segment condensation
US5739023A (en) * 1993-08-27 1998-04-14 Holland Sweetener Company V.O.F. Stabilized neutral metalloprotease composition, a method of making the composition, and a method of transporting the composition
WO1998016546A1 (en) * 1996-10-15 1998-04-23 Holland Sweetener Company V.O.F. ENZYMATIC METHOD FOR PRODUCING N-FORMYL-α-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739023A (en) * 1993-08-27 1998-04-14 Holland Sweetener Company V.O.F. Stabilized neutral metalloprotease composition, a method of making the composition, and a method of transporting the composition
US5502165A (en) * 1994-04-04 1996-03-26 Merck & Co., Inc. Process for peptide segment condensation
US5773575A (en) * 1994-04-04 1998-06-30 Merck & Co., Inc. Process for peptide segment condensation
WO1998016546A1 (en) * 1996-10-15 1998-04-23 Holland Sweetener Company V.O.F. ENZYMATIC METHOD FOR PRODUCING N-FORMYL-α-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER
US5837483A (en) * 1996-10-15 1998-11-17 Holland Sweetener Company V.O.F. Enzymatic method for producing N-formyl-α-L-aspartyl-L-phenylalanine methyl ester

Also Published As

Publication number Publication date
JPH0634745B2 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
EP0127411B1 (en) Method of preparing alpha-l-aspartyl-l-phenylalanine methyl ester and its hydrochloride
JPH11508452A (en) Novel method for producing peptides and N-carbamoyl protected peptides
TWI344819B (en) Manufacture method of sugar chain asparagine derivatives
EP0092933B1 (en) Process for producing alpha-l-aspartyl-l-phenylalanine methyl ester or its hydrochloride
EP0149594A2 (en) Enzymatic coupling of n-formyl amino acids and/or peptide residues
JPS5836399A (en) Production of human insulin derivative
US4680403A (en) Process for producing N-protected-α-L-aspartyl-L-phenylalanine methyl ester
JPH10237030A (en) Purification of branched chain amino acid
JPS62259597A (en) Enzymic synthesis of n-protected peptide
US6617127B2 (en) Synthesis and recovery of aspartame involving enzymatic deformylation step
US5693485A (en) Enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester
JPH0570638B2 (en)
EP0768384B1 (en) Improved enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester
WO2000037486A1 (en) Synthesis and recovery of aspartame involving enzymatic deformylation step
CN1178953C (en) Synthesis and recovery of aspartame involving enzymatic deformylation step
EP0269390B1 (en) Enzymatic l-aspartyl-l-phenylalanine alkyl ester production
JP2862167B2 (en) Method for recovering optically active amino acid derivative
JP2910228B2 (en) Method for producing α-L-aspartyl-L-phenylalanine methyl ester hydrochloride
JP3178092B2 (en) Method for producing α-L-aspartyl-L-phenylalanine methyl ester hydrochloride
JP2508803B2 (en) Process for producing α-L-aspartyl-L-phenylalanine derivative
JP3005072B2 (en) Preparation of cephalosporin derivatives
JPS59181244A (en) Optical resolution of dl-phenylalanine
JPH05284991A (en) Production of methyl ester of n-benzyloxycarbonyl-alfa-l-aspartyl-l-phenylalanine
JPH04349883A (en) Modified thermolysin-like enzyme and method for synthesizing alpha-l-aspartyl-l-phenylalanine methyl ester precursor using the same enzyme
JPS58146295A (en) Preparation of peptide